CRISPR Therapeutics AG CRSP
News
Crispr Therapeutics chief medical officer is resigning
Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment
Bluebird Bio Shares Slide 41% on Black-Box Label, Higher Price for Sickle-Cell Treatment
CRISPR, Vertex Get FDA OK of Casgevy Gene Therapy in Sickle-Cell Disease
Crispr Therapeutics, Vertex get world's first regulatory green light for CRISPR-based medicine
Crispr Therapeutics' stock soars as FDA-panel meeting raises hopes sickle-cell-disease drug will be approved
AMD, Kraft Heinz stocks surge, WeWork and CVS shares sink and other stocks on the move
Crispr Therapeutics Shares Rally Premarket After Favorable FDA Panel Meeting